Immuno-Oncology Drugs Global Market Opportunities And Strategies To 2031

Jul 2022| TBR1164D| TBRC (Publisher)

Report Highlights

Including: 1) By Type: Immune Checkpoint Inhibitors; Immune System Modulators; Other Monoclonal Antibodies; Cancer Vaccines; Others
2) By Therapeutic Application: Melanoma; Lung Cancer; Blood Cancer; Renal Cell Carcinoma; Bladder Cancer; Other Therapeutic Application
3) By End-Users: Hospitals; Clinics; Ambulatory Surgical Centers; Others
Covering: F. Hoffmann-La Roche Ltd.; Merck & Co.; Bristol-Myers Squibb Company; Amgen Inc.; Johnson & Johnson

Immuno-Oncology Drugs Global Market Opportunities And Strategies To 2031 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global immuno-oncology drugs market as it emerges from the COVID 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Description:
Where is the largest and fastest growing market for immuno-oncology drugs? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The immuno-oncology drugs market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider immuno-oncology drugs market; and compares it with other markets.

The report covers the following chapters

  • Executive Summary – The executive summary section of the report gives a brief overview and summary of the report
  • Report Structure – This section gives the structure of the report and the information covered in the various sections.
  • Introduction – The introduction section of the report gives brief introduction about segmentation by geography, segmentation by type, segmentation by therapeutic application, and segmentation by end users.
  • Market Characteristics – The market characteristics section of the report defines and explains the immuno-oncology drugs market. This chapter also defines and describes goods and related services covered in the report.
  • Trends And Strategies – This chapter describes the major trends shaping the global immuno-oncology drugs market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • Impact of COVID-19 – This section describes the impact of COVID-19 on the immuno-oncology drugs market.
  • Global Market Size And Growth – This section contains the global historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional Analysis – This section contains the historic (2016-2021) and forecast (2021-2026, and 2026-2031) market values and growth and market share comparison by region.
  • Segmentation – This section contains the market values (2016-2031) and analysis for different segments.
  • Regional Market Size and Growth – This section contains the region’s market size (2021), historic (2016-2021) and forecast (2021-2026, and 2026-2031) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
  • Competitive Landscape – This section covers details on the competitive landscape of the global immuno-oncology drugs market, estimated market shares and company profiles for the leading players.
  • Key Mergers And Acquisitions – This section gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies – This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Conclusion and Recommendations – This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for immuno-oncology drugs providers in terms of product offerings, geographic expansion, marketing strategies and target groups.
  • Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Frequently Asked Questions (FAQs)

Scope

Markets Covered:

  • By Type: Immune Checkpoint Inhibitors; Immune System Modulators; Other Monoclonal Antibodies; Cancer Vaccines; Others
  • By Therapeutic Application: Melanoma; Lung Cancer; Blood Cancer; Renal Cell Carcinoma; Bladder Cancer; Other Therapeutic Application
  • By End-Users: Hospitals; Clinics; Ambulatory Surgical Centers; Others

Companies Mentioned: F. Hoffmann-La Roche Ltd.; Merck & Co.; Bristol-Myers Squibb Company; Amgen Inc; Johnson & Johnson

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; immuno-oncology drugs indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

  • Table 1 : Global Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 2 : Global Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 3 : Global Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 4 : Global Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 5 : Global Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 6 : Global Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 7 : Global Immuno-Oncology Drugs Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 8 : Global Immuno-Oncology Drugs Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 9 : Global Immuno-Oncology Drugs Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 10 : Global Immuno-Oncology Drugs Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 11 : Global Immuno-Oncology Drugs Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 12 : Global Immuno-Oncology Drugs Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 13 : Asia Pacific GDP Per Capita, 2015-2020, $
  • Table 14 : Asia-Pacific, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 15 : Asia-Pacific Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 16 : Asia-Pacific Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 17 : Asia-Pacific Healthcare Services Market Size, 2016-2026, $ Billion
  • Table 18 : Asia Pacific Cancer Prevalence, Estimated Average Expenditure, 2019, $
  • Table 19 : Asia-Pacific Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 20 : Asia-Pacific Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 21 : Asia-Pacific Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 22 : Asia-Pacific Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 23 : Asia-Pacific Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 24 : Asia-Pacific Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 25 : China GDP Per Capita, 2015-2020, $
  • Table 26 : China, Population By Age Group, 2015-2025, Thousands
  • Table 27 : China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 28 : China Healthcare Services Market Size, 2016-2026, $ Billion
  • Table 29 : China Cancer Prevalence, Estimated Average Expenditure, 2019, $
  • Table 30 : China Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 31 : China Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 32 : China Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 33 : China Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 34 : China Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 35 : China Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 36 : India Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 37 : India Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 38 : India Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 39 : India Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 40 : India Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 41 : India Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 42 : Japan Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 43 : Japan Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 44 : Japan Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 45 : Japan Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 46 : Japan Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 47 : Japan Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 48 : Australia Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 49 : Australia Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 50 : Australia Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 51 : Australia Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 52 : Australia Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 53 : Australia Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 54 : Indonesia Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 55 : Indonesia Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 56 : Indonesia Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 57 : Indonesia Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 58 : Indonesia Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 59 : Indonesia Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 60 : South Korea Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 61 : South Korea Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 62 : South Korea Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 63 : South Korea Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 64 : South Korea Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 65 : South Korea Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 66 : Western Europe GDP Per Capita, 2015-2020, $
  • Table 67 : Western Europe, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 68 : Western Europe Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 69 : Western Europe Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 70 : Western Europe Healthcare Services Market Size, 2016-2026, $ Billion
  • Table 71 : Western Europe Estimated Average Expenditure, Cancer Prevalence, 2019
  • Table 72 : Western Europe Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 73 : Western Europe Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 74 : Western Europe Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 75 : Western Europe Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 76 : Western Europe Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 77 : Western Europe Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 78 : UK Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 79 : UK Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 80 : UK Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 81 : UK Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 82 : UK Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 83 : UK Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 84 : Germany Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 85 : Germany Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 86 : Germany Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 87 : Germany Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 88 : Germany Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 89 : Germany Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 90 : France Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 91 : France Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 92 : France Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 93 : France Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 94 : France Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 95 : France Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 96 : Eastern Europe GDP Per Capita, 2015-2020, $
  • Table 97 : Eastern Europe, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 98 : Eastern Europe Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 99 : Eastern Europe Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 100 : Eastern Europe Healthcare Services Market Size, 2016-2026, $ Billion
  • Table 101 : Eastern Europe Estimated Average Expenditure, Cancer Prevalence, 2019
  • Table 102 : Eastern Europe Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 103 : Eastern Europe Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 104 : Eastern Europe Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 105 : Eastern Europe Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 106 : Eastern Europe Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 107 : Eastern Europe Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 108 : Russia Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 109 : Russia Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 110 : Russia Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 111 : Russia Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 112 : Russia Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 113 : Russia Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 114 : North America GDP Per Capita, 2015-2020, $
  • Table 115 : North America, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 116 : North America Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 117 : North America Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 118 : North America Healthcare Services Market Size, 2016-2026, $ Billion
  • Table 119 : North America Estimated Average Expenditure, Cancer Prevalence, 2019
  • Table 120 : North America Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 121 : North America Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 122 : North America Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 123 : North America Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 124 : North America Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 125 : North America Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 126 : USA GDP Per Capita, 2015-2020, $
  • Table 127 : USA, Population By Age Group, 2015-2025, Thousands
  • Table 128 : USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 129 : USA Healthcare Services Market Size, 2016-2026, $ Billion
  • Table 130 : USA Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 131 : USA Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 132 : USA Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 133 : USA Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 134 : USA Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 135 : USA Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 136 : South America GDP Per Capita, 2015-2020, $
  • Table 137 : South America, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 138 : South America Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 139 : South America Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 140 : South America Healthcare Services Market Size, 2016-2026, $ Billion
  • Table 141 : South America Estimated Average Expenditure, Cancer Prevalence, 2019
  • Table 142 : South America Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 143 : South America Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 144 : South America Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 145 : South America Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 146 : South America Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 147 : South America Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 148 : Brazil Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 149 : Brazil Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 150 : Brazil Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 151 : Brazil Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 152 : Brazil Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 153 : Brazil Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 154 : Middle East GDP Per Capita, 2015-2020, $
  • Table 155 : Middle East, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 156 : Middle East Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 157 : Middle East Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 158 : Middle East Healthcare Services Market Size, 2016-2026, $ Billion
  • Table 159 : Middle East Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 160 : Middle East Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 161 : Middle East Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 162 : Middle East Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 163 : Middle East Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 164 : Middle East Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 165 : Africa GDP Per Capita, 2015-2020, $
  • Table 166 : Africa, Population By Age Group, By Country, 2015-2025, Thousands
  • Table 167 : Africa Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 168 : Africa Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 169 : Africa Healthcare Services Market Size, 2016-2026, $ Billion
  • Table 170 : Africa Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Table 171 : Africa Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 172 : Africa Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 173 : Africa Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 174 : Africa Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 175 : Africa Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 176 : Global Immuno-Oncology Drugs Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
  • Table 177 : F. Hoffmann-La Roche Ltd – Financial Performance, $ Billion
  • Table 178 : Merck & Co – Financial Performance, $ Billion
  • Table 179 : Bristol-Myers Squibb – Financial Performance, $ Billion
  • Table 180 : Amgen – Financial Performance, $ Billion
  • Table 181 : J&J – Financial Performance, $ Billion
  • Table 182 : Global Immuno-Oncology Drugs Market Size Gain ($ Million), 2021 – 2026, By Country
  • Table 183 : Global Immuno-Oncology Drugs Market Size Gain ($ Million), Segmentation By Type, 2021 – 2026
  • Table 184 : Global Immuno-Oncology Drugs Market Size Gain ($ Million), Segmentation By Therapeutic Application, 2021 – 2026
  • Table 185 : Global Immuno-Oncology Drugs Market Size Gain ($ Million), Segmentation By End User, 2021 – 2026
  • Table 186 : Immuno-Oncology Drugs - Market Data Sources
  • Figure 1 : Global Immuno-Oncology Drugs Market Segmentation By Type
  • Figure 2 : Global Immuno-Oncology Drugs Market Segmentation By Therapeutic Application
  • Figure 3 : Global Immuno-Oncology Drugs Market Segmentation By End Users
  • Figure 4 : Global Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 5 : Global Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 6 : Global Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 7 : Global Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 8 : Global Immuno-Oncology Drugs Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 9 : Global Immuno-Oncology Drugs Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 10 : Global Immuno-Oncology Drugs Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 11 : Asia-Pacific Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 12 : Asia-Pacific Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 13 : Asia-Pacific Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 14 : Asia-Pacific Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 15 : China Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 16 : China Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 17 : China Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 18 : China Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 19 : India Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 20 : India Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 21 : India Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 22 : India Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 23 : Japan Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 24 : Japan Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 25 : Japan Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 26 : Japan Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 27 : Australia Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 28 : Australia Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 29 : Australia Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 30 : Australia Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 31 : Indonesia Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 32 : Indonesia Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 33 : Indonesia Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 34 : Indonesia Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 35 : South Korea Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 36 : South Korea Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 37 : South Korea Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 38 : South Korea Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 39 : Western Europe Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 40 : Western Europe Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 41 : Western Europe Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 42 : Western Europe Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 43 : UK Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 44 : UK Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 45 : UK Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 46 : UK Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 47 : Germany Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 48 : Germany Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 49 : Germany Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 50 : Germany Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 51 : France Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 52 : France Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 53 : France Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 54 : France Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 55 : Eastern Europe Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 56 : Eastern Europe Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 57 : Eastern Europe Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 58 : Eastern Europe Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 59 : Russia Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 60 : Russia Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 61 : Russia Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 62 : Russia Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 63 : North America Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 64 : North America Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 65 : North America Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 66 : North America Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 67 : USA Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 68 : USA Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 69 : USA Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 70 : USA Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 71 : South America Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 72 : South America Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 73 : South America Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 74 : South America Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 75 : Brazil Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 76 : Brazil Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 77 : Brazil Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 78 : Brazil Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 79 : Middle East Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 80 : Middle East Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 81 : Middle East Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 82 : Middle East Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 83 : Africa Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
  • Figure 84 : Africa Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 85 : Africa Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 86 : Africa Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 87 : Global Immuno-Oncology Drugs Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
  • Figure 88 : F. Hoffmann-La Roche Ltd.– Financial Performance, $ Billion
  • Figure 89 : Merck & Co – Financial Performance, $ Billion
  • Figure 90 : Bristol-Myers Squibb – Financial Performance, $ Billion
  • Figure 91 : Amgen – Financial Performance, $ Billion
  • Figure 92 : J&J – Financial Performance, $ Billion

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Similar Reports from TBRC (Publisher)

Immuno-Oncology Drugs Global Market Report 2022

  • Date - Mar 2022
  • Code - TBR1164C

Including: 1) By Type: Monoclonal Antibodies; Immune Checkpoint Inhibitors; Immune System Modulators; Cancer Vaccines; Others
2) By Therapeutic Application: Melanoma; Lung Cancer; Blood Cancer; Renal Cell Carcinoma; Prostate Cancer; Bladder Cancer; Others
3) By End-User: Hospitals; Clinics; Ambulatory Surgical Centers; Cancer Research Institutes
Covering: Amgen inc.; AstraZeneca plc.; Bristol-Myers Squibb; Celgene Corporation; Eli Lilly and Company; Merck & ...

Immuno-Oncology Drugs Global Market Report 2021: COVID-19 Growth And Change To 2030

  • Date - Sep 2021
  • Code - TBR1164B

Including: 1) By Type: Monoclonal Antibodies; Immune Checkpoint Inhibitors; Immune System Modulators; Cancer Vaccines; Others
2) By Therapeutic Application: Melanoma; Lung Cancer; Blood Cancer; Renal Cell Carcinoma; Prostate Cancer; Bladder Cancer; Others
3) By End-User: Hospitals; Clinics; Ambulatory Surgical Centers; Cancer Research Institutes
Covering: Amgen, Inc.; AstraZeneca Plc; Bristol-Myers Squibb; Celgene Corporation; Eli Lilly and Company

Immuno-Oncology ...

Immuno-Oncology Drugs Global Market Report 2020-30: COVID-19 Growth and Change

  • Date - Dec 2020
  • Code - TBR1164A

Immuno-Oncology Drugs Global Market Report 2020-30: COVID-19 Growth and Change

Including: 1) By Type: Monoclonal Antibodies; Immune Checkpoint Inhibitors; Immune System Modulators; Cancer Vaccines; Others
2) By Therapeutic Application: Melanoma; Lung Cancer; Blood Cancer; Renal Cell Carcinoma; Prostate Cancer; Bladder Cancer; Others
3) By End-user: Hospitals; Clinics; Ambulatory Surgical Centers; Cancer Research Institutes

Covering: Amgen, Inc.; AstraZeneca Plc; Bristol-Myers Squibb; ...

The Business Research Company
Price: $5000

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS